Member Info for Timster

https://bit.ly/32AQJGi

But yesterday it was linked to Avacata by directors talk :(

https://www.*************.net/test-hailed-as-game-changer-in-fight-against-covid-19/

needs to be removed

PL75 mentioned it yesterday, its purely because its Medusa. It is nothing to do with Avacta, Directors talk should really remove the article.

Clinical Validation isn't the problem here. Sir Al is oozing with confidence that we will fly it:

The excellent analytical performance of the ELISA test is very encouraging with regards to the anticipated clinical performance of the rapid test

Authorities around the world are now looking to carry-out frequent mass testing to identify the most infectious people promptly in order to reduce infection rates and combat the coronavirus pandemic. That requires a highly specific test to minimize false positives which would otherwise overwhelm healthcare systems. The Affimer reagents that we have generated are very specific to SARS-CoV-2 antigen and we are confident of meeting and exceeding the clinical performance requirements for identifying the most infectious people.

The issue is the manufaturers ramping up and as posted yesterday the equipment they need has a long lead time:

Manufacturing capacity is therefore the key challenge that has to be met in achieving widespread roll-out of Avacta's saliva-based rapid antigen test. We therefore continue to actively seek additional manufacturing partners globally to be able to provide the volume of tests that will be required in the UK and elsewhere. I look forward to updating the market on progress in that regard, and will keep the market informed on the key next steps of clinical validation and regulatory approval.

All of his tweets regarding lateral flow have been removed!

think he probably realised he amassed a following of traders and not scientists and someone told him to button it

And two counties in Wales 400k people... It's not gone yet

As stated in the manufacturing RNS:
Manufacturing capacity is therefore the key challenge that has to be met in achieving widespread roll-out of Avacta's saliva-based rapid antigen test. We therefore continue to actively seek additional manufacturing partners globally to be able to provide the volume of tests that will be required in the UK and elsewhere. I look forward to updating the market on progress in that regard, and will keep the market informed on the key next steps of clinical validation and regulatory approval."

Not clinical validation the problem , but manufacturing scale up...

Relax it's all in hand

Wiggly, you've gone all xxxyyyzzz on us.

With all this speculation though it would be good to know what's going on. But we do know what's going on we are waiting for clinical validation.

Sorry but phuck the Chinese....

The new double act, it's laughable

@Livedata now you've done it.....

Oh no he didn't!!

Sorry...

Leak !!! .1% up

Those massive trades got us off to a flyer...

When did he say that?

@girlupnorth don't mean to pry, but your post is written as though you expressed your concerns to someone that might be important e.g the company, the government. If you do have the ear of useful people have you told them Affimers are the dogs ******?
or did you just mean to this forum?

our LFT hasnt gone away, it's still using the same Affimers as the ELISA test. It's still on target to be a world changer

He was probably the big after hours buy yesterday ;)

in conjunction with getting sporting events back on track?

You carry on, I'm not the messiah

Medusa? who are they, well this is slightly concerning